Beta-blocker heart attack trial study protocol

LDR			01473cam a2200397Ia 4500
001			011324588
003			MiAaHDL
005			20110215000000.0
006			m d
007			cr bn ---auaua
008			810706s1980 mdu b f000 0 eng d
035	⊔	⊔	‡asdr-pur2606326
035	⊔	⊔	‡a2606326
035	⊔	⊔	‡a(OCoLC)7556770
040	⊔	⊔	‡aGPO ‡cGPO ‡dWAU ‡dSYB
049	⊔	⊔	‡aIPL1
050	⊔	4	‡aRC684.A35 ‡bB3
074	⊔	⊔	‡a507-E-1
086	0	⊔	‡aHE 20.3202:B 46/980
096	⊔	⊔	‡aWG 300 N278b 1980
245	0	0	‡aBeta-blocker heart attack trial study protocol / ‡cNational Heart, Lung, and Blood Institute.
250	⊔	⊔	‡aJuly 1980 update.
260	⊔	⊔	‡a[Bethesda, Md.?] : ‡bU.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, ‡c1980.
300	⊔	⊔	‡a46 p. in various pagings
490	0	⊔	‡aNIH publication ; ‡vno. 81-2209
500	⊔	⊔	‡a"November 1980."
500	⊔	⊔	‡aPrevious ed. issued June 1978.
504	⊔	⊔	‡aIncludes bibliographical references.
538	⊔	⊔	‡aMode of access: Internet.
650	⊔	2	‡aMyocardial Infarction ‡xprevention & control.
650	⊔	2	‡aCoronary Disease ‡xcomplications.
650	⊔	2	‡aPropranolol ‡xtherapeutic use.
650	⊔	2	‡aAdrenergic beta-Antagonists.
650	⊔	0	‡aHeart ‡xInformation.
650	⊔	0	‡aHeart ‡xEffect of drugs on.
650	⊔	0	‡aAdrenergic beta blockers.
710	2	⊔	‡aNational Institutes of Health (U.S.)
710	2	⊔	‡aNational Heart, Lung, and Blood Institute.
CID	⊔	⊔	‡a011324588
DAT	0	⊔	‡a20101018002928.0 ‡b20110215000000.0
DAT	1	⊔	‡a20120815064345.0 ‡b2024-09-29T18:27:18Z
DAT	2	⊔	‡a2024-09-29T17:30:02Z
CAT	⊔	⊔	‡aSDR-PUR ‡dUNKNOWN ‡lloader.pl-001-001
FMT	⊔	⊔	‡aBK
HOL	⊔	⊔	‡0sdr-pur2606326 ‡apur1 ‡bSDR ‡cPUR ‡ppur1.32754081210092 ‡sPUR ‡12606326
974	⊔	⊔	‡bPUR ‡cPUR ‡d20240929 ‡sgoogle ‡upur1.32754081210092 ‡y1980 ‡rpd ‡qbib ‡tUS fed doc